Carlyle-backed Indegene clocks 26% gain on stock market debut
Indegene Ltd, a technology-led healthcare solutions provider to biopharmaceutical, biotech and medical devices companies, made a strong stock market debut on Monday with its shares gaining 26.25% on the first day of trade. Shares of Indegene, backed by private equity firm Carlyle, listed on BSE Ltd at Rs 659.70 apiece, up 46% ......
Carlyle-backed Indegene makes another overseas acquisition
Indegene, a technology-led healthcare solutions provider to biopharmaceutical, biotech and medical devices companies, has acquired another overseas company to ramp up its service offerings. The Indian company, which is backed by US-based private equity firm Carlyle, has purchased medical writing consultancy firm Trilogy Writing & Consulting GmbH. Indegene said in a statement Trilogy's acquisition will ......
Carlyle-backed Indegene’s IPO gets bumper response; Aadhar Housing, TBO Tek make slow start
Three companies that are backed by private equity investors hit the market this week, with two launching their bids on Wednesday and one seeing a spectacular response from investors on the final day. Indegene Ltd, backed by Carlyle and Nadathur Holdings, recorded subscription of 69.66 times the shares on offer. It ......
Indegene, Mamaearth parent get SEBI approval for IPO
Private equity and venture capital-backed firms Indegene, a pharma player and skincare brand Mamaearth’s parent Honasa Consumer have received approval from Securities and Exchange Board of India (Sebi) for their respective initial public offerings. Both companies had filed preliminary papers with the market regulator in December 2022, with an aim to ......
Check out India's biggest 2024 IPOs as stock markets boom
Here are some details of this year's biggest initial public offerings (IPOs) in India, where stock markets are booming and Ola Electric, the country's biggest e-scooter maker, will launch its highly anticipated IPO on Thursday. More than 150 companies have raised nearly $5 billion through IPOs between January and July, nearly ......
Carlyle makes a partial exit from IPO-bound Indegene
Private equity firm Carlyle has trimmed its stake in Indegene, just two years after teaming up with another investment firm to joint betting $200 million (Rs 1,500 crore then) on the healthtech venture. Carlyle had joined hands with Brighton Park Capital, a private investment firm that focuses on software, information services, ......
Carlyle, two others to pare stakes in Indegene via IPO route
US private equity giant Carlyle and two other investors are planning to make partial exits from Indegene Ltd through an initial share sale of the technology-led healthcare solutions provider worth up to ₹3,200 crore. Carlyle along with Brighton Park Capital and the Nadathur Family Office are proposing to sell less than ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News